Handbook of Biologically Active PeptidesAbba Kastin Academic Press, 26 ian. 2013 - 2032 pagini Handbook of Biologically Active Peptides, Second Edition, is the definitive, indispensable reference for peptide researchers, biochemists, cell and molecular biologists, neuroscientists, pharmacologists, and endocrinologists. Its chapters are designed to be a source for workers in the field and enable researchers working in a specific area to examine related areas outside their expertise. Peptides play a crucial role in many physiological processes, including actions as neurotransmitters, hormones, and antibiotics. Research has shown their importance in such fields as neuroscience, immunology, pharmacology, and cell biology. The second edition of Handbook of Biologically Active Peptides presents this tremendous body of knowledge in the field of biologically active peptides in one single reference. The section editors and contributors represent some of the most sophisticated and distinguished scientists working in basic sciences and clinical medicine.
|
Cuprins
Chapter 132 Ghrelin | 996 |
Chapter 133 Leptin | 1005 |
Chapter 134 ANP | 1011 |
Chapter 135 Neuromedins US | 1019 |
Chapter 136 Neuropeptide BW | 1025 |
Chapter 137 Orexins | 1032 |
Chapter 138 PACAP | 1038 |
Chapter 139 AdiponectinResistin | 1045 |
40 | |
46 | |
50 | |
53 | |
58 | |
67 | |
71 | |
77 | |
85 | |
93 | |
101 | |
119 | |
129 | |
138 | |
150 | |
Chapter 23 Antifungal and Antibacterial Peptides of Fungal Origin | 157 |
Chapter 24 Fungal Peptides with Ribonuclease and Ribosome Inactivating Activities | 162 |
Chapter 25 Fungal Toxins | 166 |
Chapter 26 Plant Antifungal Peptides | 169 |
Chapter 27 Polysaccaride Krestin PSK and Polysaccharopeptide PSP | 180 |
Chapter 28 AKHRPCH Peptides | 185 |
Chapter 29 Allatostatins | 191 |
Chapter 30 Allatotropin | 197 |
Chapter 31 BType Allatostatins and Sex Peptides | 203 |
Chapter 32 Crustacean Bioactive Peptides | 209 |
ETH Corazonin and PTTH | 222 |
Chapter 34 DiureticAntidiuretic | 229 |
Chapter 35 FMRFamideLike Peptides FLPs | 237 |
Chapter 36 FreeLiving Nematodes | 247 |
Chapter 37 FXPRLamide PyrokininPBAN Family | 255 |
Chapter 38 InsulinLike Peptides | 267 |
Chapter 39 Molluscan Bioactive Peptides | 276 |
Chapter 40 Parasitic Nematode Peptides | 287 |
Chapter 41 Pigment Dispersing Factor | 298 |
Chapter 42 Proctolin | 304 |
Chapter 43 Sulfakinins | 310 |
Chapter 44 Tachykinin Peptides | 315 |
Chapter 45 Bradykinin Peptides | 321 |
Chapter 46 Bombesin Peptides | 326 |
Chapter 47 Bombinins | 331 |
Chapter 48 Caeruleins | 338 |
Chapter 49 ChromograninsSecretogranins | 342 |
Chapter 50 Dermaseptins | 350 |
Chapter 51 InsulinReleasing Peptides | 364 |
Chapter 52 Neurohypophysial Peptides | 371 |
Chapter 53 Opioid and Bv8 Peptides | 376 |
Chapter 54 Sodefrin and Related Pheromones | 384 |
Chapter 55 Tachykinins | 391 |
Chapter 56 Temporins | 400 |
Chapter 57 Animal Toxins | 407 |
Chapter 58 Hymenoptera Insect Peptides | 416 |
Chapter 59 Scorpion Peptides | 423 |
Chapter 60 Sea Anemone Peptides | 430 |
Chapter 61 Snail Peptides | 437 |
Chapter 62 Snake Peptides | 451 |
Chapter 63 Spider Peptides | 461 |
Chapter 64 Targets and Therapeutic Properties | 473 |
Chapter 65 Worm Peptides | 483 |
Chapter 66 Adrenomedullin | 489 |
Chapter 67 Angiotensin IIAngiotensin17 | 494 |
Chapter 68 Apelin | 502 |
Chapter 69 Bombesin Peptides | 506 |
Chapter 70 Endothelin1 | 512 |
Chapter 71 Gastrin | 519 |
Chapter 72 LeptinAdiponectin | 524 |
Chapter 73 LHRH Analogs | 531 |
Chapter 74 Orexins Hypocretins | 541 |
Chapter 75 SomatostatinNPY | 548 |
Chapter 76 VIPPACAP Receptors | 556 |
Chapter 77 Antiadhesin PeptideBased Vaccines for Pseudomonas aeruginosa | 563 |
Chapter 78 LipoPeptidesSaccharides for Peptide Vaccine Delivery | 571 |
Chapter 79 Novel Tumor Derived Peptides in Vaccines | 580 |
Chapter 80 Peptide Vaccine for Alzheimers Disease | 590 |
Chapter 81 Peptide Vaccines for Myeloid Leukemias | 596 |
Chapter 82 Peptide Vaccines for Otitis Media | 603 |
Chapter 83 Therapeutic Peptides Targeting HER2neu and VEGF Signaling Pathways in Breast Cancer | 612 |
Chapter 84 Use of Positional Scanning Libraries to Identify Immunologically Relevant Peptides | 617 |
Chapter 85 Anaphylatoxins | 625 |
Chapter 86 AnnexinA1 Peptide Ac226 | 631 |
Chapter 87 Immunoregulatory Neuropeptides | 640 |
Chapter 88 Chemerin | 649 |
Chapter 89 Chemokines | 656 |
Chapter 90 DP IVCD26 Effector Peptides | 664 |
Chapter 91 FPR Ligands | 671 |
Chapter 92 Neuroimmune Peptides | 681 |
Chapter 93 Peptide Loading of MHC | 687 |
Chapter 94 Peptide Recognition by T Cells | 697 |
Chapter 95 RGD Peptides | 705 |
Chapter 96 Apelin | 715 |
Chapter 97 BNPCNP | 724 |
Chapter 98 CART | 732 |
Chapter 99 CCK | 738 |
Chapter 100 CGRPAdrenomedullin | 744 |
Chapter 101 CRH Family | 752 |
Chapter 102 Endozepines | 760 |
Chapter 103 Galanin and GALP | 766 |
Chapter 104 Ghrelin | 776 |
Chapter 105 GHRH | 784 |
Chapter 106 GnRH LHRH | 792 |
Chapter 107 GonadotropinInhibitory Hormone | 802 |
Chapter 108 Hypocretins Orexins | 812 |
Chapter 109 Kisspeptins | 819 |
Chapter 110 MCH | 828 |
Chapter 111 Melanocortins | 838 |
Chapter 112 MIF1TyrMIF1 | 845 |
Chapter 113 Nesfatin1 | 850 |
Chapter 114 Neuromedin U | 856 |
Chapter 115 Neuropeptide BW | 863 |
Chapter 116 Neuropeptide S | 869 |
Chapter 117 NeurotensinNeuromedin N | 875 |
Chapter 118 NPY | 883 |
Chapter 119 PACAP | 889 |
Chapter 120 ProlactinReleasing Peptide | 898 |
Chapter 121 Relaxins | 907 |
Chapter 122 26RFa | 917 |
Chapter 123 Secretin | 924 |
Chapter 124 SomatostatinCortistatin | 933 |
Chapter 125 Tachykinins | 943 |
Chapter 126 TRH | 951 |
Chapter 127 Urotensin II Peptides | 957 |
Chapter 128 VIP | 966 |
Chapter 129 VPOT | 975 |
Chapter 130 Adiponectin | 983 |
Chapter 131 Adrenomedullin Peptides | 990 |
Chapter 140 AmylinCGRP | 1049 |
Chapter 141 Apolipoprotein apo AIVapoE | 1057 |
Chapter 142 Bombesin | 1064 |
Chapter 143 CART | 1071 |
Chapter 144 CCK | 1077 |
Chapter 145 CRH | 1084 |
Chapter 146 Enterostatin | 1089 |
Chapter 147 Galanin | 1097 |
Chapter 148 Ghrelin | 1104 |
Chapter 149 GLP1 | 1111 |
Chapter 150 Glucagon | 1118 |
Chapter 151 Insulin | 1123 |
Chapter 152 Leptin | 1129 |
Chapter 153 Melanocortins | 1135 |
Chapter 154 NPY | 1143 |
Chapter 155 Opioids | 1149 |
Chapter 156 Orexin | 1154 |
Chapter 157 PYY | 1160 |
Chapter 158 Adrenomedullin | 1167 |
Chapter 159 Angiogenic Growth Factors | 1172 |
Chapter 160 Apelin | 1182 |
Chapter 161 BombesinRelated Peptides | 1188 |
Chapter 162 CCK | 1197 |
Chapter 163 CGRP | 1204 |
Chapter 164 Galanin | 1210 |
Chapter 165 Gastrin | 1219 |
Chapter 166 GIP | 1227 |
Chapter 167 Ghrelin | 1236 |
Chapter 168 GLP 12 Enteroglucagon Glicentin and Oxyntomodulin | 1241 |
Chapter 169 Leptin | 1251 |
Chapter 170 Motilin | 1257 |
Chapter 171 Neurotensin | 1265 |
Chapter 172 Nesfatin1 | 1271 |
Chapter 173 Obestatin | 1275 |
Chapter 174 Opioids | 1283 |
Chapter 175 PACAP | 1289 |
Chapter 176 Pancreatic Polypeptide | 1294 |
Chapter 177 Paneth Cell αDefensins | 1300 |
Chapter 178 PYY | 1307 |
Chapter 179 Secretin | 1314 |
Chapter 180 Somatostatin | 1320 |
Chapter 181 Tachykinins | 1330 |
Chapter 182 TFF Peptides | 1338 |
Chapter 183 Urocortins | 1346 |
Chapter 184 VIP | 1354 |
Chapter 185 Adrenomedullin Peptides | 1361 |
Chapter 186 Angiotensin II Peptides | 1369 |
Chapter 187 Apelin | 1377 |
Chapter 188 Bradykinin Peptides | 1386 |
Chapter 189 CGRP | 1394 |
Chapter 190 Endothelins | 1402 |
Chapter 191 Ghrelin | 1408 |
Chapter 192 Natriuretic Peptides | 1415 |
Chapter 193 Salusins | 1423 |
Chapter 194 Urocortins | 1428 |
Chapter 195 Urotensin Peptides | 1437 |
Chapter 196 VIP | 1443 |
Chapter 197 VPOT | 1450 |
Chapter 198 Adrenomedullin 2Intermedin | 1459 |
Chapter 199 ANP | 1467 |
Chapter 200 Endothelin | 1473 |
Chapter 201 Neurohypophyseal Peptides | 1481 |
Chapter 202 Peptides Sex Diabetes and the Kidney | 1487 |
Chapter 203 Prolactin | 1494 |
Chapter 204 ReninAngiotensin System | 1499 |
Chapter 205 Adrenomedullin | 1507 |
Chapter 206 Endothelin1 | 1513 |
Chapter 207 Kinin Receptors | 1519 |
Chapter 208 PACAP | 1527 |
Chapter 209 VIP | 1535 |
Chapter 210 Antiopioid Peptides | 1543 |
Chapter 211 CasomorphinsHemorphins | 1550 |
Chapter 212 Endomorphins | 1556 |
Chapter 213 Evolution of the Opioid System | 1562 |
Chapter 214 Exorphins | 1570 |
Chapter 215 NociceptinOrphanin FQ | 1577 |
Chapter 216 OpioidSubstance P Chimeric Peptides | 1586 |
Chapter 217 POMCDerived Opioid Peptides | 1592 |
Chapter 218 ProdynorphinDerived Peptides | 1596 |
Chapter 219 ProenkephalinDerived Peptides | 1602 |
Chapter 220 ActivityDependent Neuroprotective Protein ADNP and Davunetide NAP | 1611 |
Chapter 221 Erythropoietin | 1619 |
Chapter 222 Insulinlike Growth Factor1 | 1627 |
Chapter 223 Neuregulins | 1633 |
Chapter 224 Neurotrophins | 1639 |
Chapter 225 TGFβ | 1647 |
Chapter 226 Augurin and Ecrg4derived Neuropeptides | 1655 |
Alzheimers Obesity and Beyond | 1667 |
Chapter 228 Hypothalamic Neuropeptides | 1672 |
Chapter 229 Ingestive Peptides | 1677 |
Chapter 230 Neurotrophic Peptides | 1682 |
Chapter 231 Oligopeptide and PeptideLike Drug Transport | 1688 |
Chapter 232 Opioid Peptides | 1696 |
Chapter 233 Peptide Delivery | 1702 |
Chapter 234 Acetylation | 1711 |
Chapter 235 Carboxypeptidases E and D | 1715 |
Chapter 236 Disulfide Bond Formation | 1721 |
Chapter 237 Ghrelin OAcyltransferase GOAT | 1730 |
Chapter 238 Glutaminyl Cyclases | 1736 |
Chapter 239 In Silico Search for Biologically Active Peptides | 1743 |
Chapter 240 New Mass Spectrometric Approaches for Uncovering Neuropeptides | 1749 |
Chapter 241 Peptide Degradation Neprilysin and Other Regulatory Peptidases | 1757 |
Chapter 242 Peptidomics of Mice Lacking Peptide Processing Enzymes | 1765 |
Chapter 243 Peptidomics Strategy for Discovering Endogenous Biologically Active Peptides | 1772 |
Chapter 244 Peptidylglycine Amidating Monoxygenase PAM | 1780 |
Chapter 245 Prohormone Convertase 13 | 1789 |
Chapter 246 Prohormone Convertase 2 | 1797 |
Chapter 247 Proprotein Convertase Furin and Proprotein Convertase PC56 | 1803 |
Chapter 248 Proprotein Convertases PC4 PACE4 and PC7 | 1812 |
Chapter 249 Proprotein Convertases SKI1S1P and PCSK9 | 1821 |
Chapter 250 Tyrosylprotein sulfotransferases | 1829 |
Chapter 251 Classical Neurotransmitters and Neuropeptides | 1835 |
Skin Peptides | 1842 |
Chapter 253 Peptide Chronomics | 1850 |
Chapter 254 Peptides and Behavior | 1858 |
Chapter 255 Peptides and Sleep | 1864 |
Chapter 256 Peptides and Stress | 1872 |
Chapter 257 Peptides and Temperature | 1880 |
Chapter 258 Pheromone Peptides | 1889 |
Chapter 259 Prebiotic Peptides | 1899 |
Chapter 260 Viral Fusion Peptides | 1904 |
1913 | |
Color Plates | 1943 |